SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-036920
Filing Date
2023-05-05
Accepted
2023-05-05 16:36:02
Documents
90
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2022_nlspharma.htm   iXBRL 20-F 1718245
2 DESCRIPTION OF SECURITIES f20f2022ex2-1_nlspharma.htm EX-2.1 111376
3 AMENDMENT NO. 1 TO PRE-FUNDED WARRANT DATED APRIL [__], 2023 BETWEEN NLS PHARMAC f20f2022ex4-17_nlspharma.htm EX-4.17 25609
4 CERTIFICATION f20f2022ex12-1_nlspharma.htm EX-12.1 9729
5 CERTIFICATION f20f2022ex12-2_nlspharma.htm EX-12.2 9703
6 CERTIFICATION f20f2022ex13-1_nlspharma.htm EX-13.1 3640
7 CERTIFICATION f20f2022ex13-2_nlspharma.htm EX-13.2 3485
8 CONSENT OF PRICEWATERHOUSECOOPERS AG f20f2022ex15-1_nlspharma.htm EX-15.1 5288
9 GRAPHIC image_001.jpg GRAPHIC 23053
10 GRAPHIC image_002.jpg GRAPHIC 24993
11 GRAPHIC image_003.jpg GRAPHIC 10760
12 GRAPHIC image_004.jpg GRAPHIC 10771
13 GRAPHIC image_005.jpg GRAPHIC 7011
14 GRAPHIC image_006.jpg GRAPHIC 18434
15 GRAPHIC image_007.jpg GRAPHIC 15388
16 GRAPHIC image_008.jpg GRAPHIC 17602
17 GRAPHIC image_009.jpg GRAPHIC 24015
18 GRAPHIC image_010.jpg GRAPHIC 30348
19 GRAPHIC image_011.jpg GRAPHIC 13115
20 GRAPHIC image_012.jpg GRAPHIC 22595
21 GRAPHIC image_013.jpg GRAPHIC 11242
22 GRAPHIC image_014.jpg GRAPHIC 18456
23 GRAPHIC image_015.jpg GRAPHIC 13760
24 GRAPHIC image_016.jpg GRAPHIC 18611
25 GRAPHIC image_017.jpg GRAPHIC 36321
26 GRAPHIC image_018.jpg GRAPHIC 18610
  Complete submission text file 0001213900-23-036920.txt   7228530

Data Files

Seq Description Document Type Size
27 XBRL SCHEMA FILE nlsp-20221231.xsd EX-101.SCH 74076
28 XBRL CALCULATION FILE nlsp-20221231_cal.xml EX-101.CAL 34292
29 XBRL DEFINITION FILE nlsp-20221231_def.xml EX-101.DEF 244557
30 XBRL LABEL FILE nlsp-20221231_lab.xml EX-101.LAB 550793
31 XBRL PRESENTATION FILE nlsp-20221231_pre.xml EX-101.PRE 264369
84 EXTRACTED XBRL INSTANCE DOCUMENT f20f2022_nlspharma_htm.xml XML 583382
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39957 | Film No.: 23894474
SIC: 2834 Pharmaceutical Preparations